News & Updates

Obstructive sleep apnoea warrants early diagnosis as the repercussions can be deadly if left ignored.

01 Sep 2022 by

With the increase in obese and overweight patients, physicians may need to have a high degree of suspicion for obstructive sleep apnoea (OSA), says a prominent respirologist.

Obstructive sleep apnoea warrants early diagnosis as the repercussions can be deadly if left ignored.

01 Sep 2022

AI-assisted colonoscopy improves polyp detection

01 Sep 2022 by

Artificial intelligence (AI)–assisted colonoscopy improves adenoma detection in asymptomatic individuals undergoing colorectal cancer (CRC) screening, a multicentre randomized controlled trial (RCT) has shown.

AI-assisted colonoscopy improves polyp detection

01 Sep 2022

Do multivitamins increase prostate cancer risk in older men?

31 Aug 2022

Taking multivitamins regularly or for a long duration neither heightens nor reduces the risk of overall or aggressive prostate cancer among older, generally well-nourished men, results of a study have shown.

Do multivitamins increase prostate cancer risk in older men?

31 Aug 2022

Higher dietary glycaemic index, load up CVD mortality risk

31 Aug 2022 by

A dietary pattern with increased glycaemic index (GI) and load (GL) appears to elevate the risk of death due to cardiovascular diseases (CVDs), suggests a study involving Chinese adults.

Higher dietary glycaemic index, load up CVD mortality risk

31 Aug 2022

Gender dysphoria more prevalent in younger adults

31 Aug 2022

Gender dysphoria (GD) appears to be more common than previously estimated by clinic-based studies, according to the results of a population-based internet survey in Japan. In addition, GD more frequently correlates with age than with gender.

Gender dysphoria more prevalent in younger adults

31 Aug 2022

Anti-GMAbs predict Crohn’s disease years before diagnosis

31 Aug 2022 by

The presence of autoantibodies against the granulocyte macrophage-colony stimulating factor (aGMAb) appears to precede Crohn’s disease (CD) diagnosis by years, according to a recent study. AGMAbs could be used for the prediction of complicated CD.

Anti-GMAbs predict Crohn’s disease years before diagnosis

31 Aug 2022

Dual therapy as good as triple therapy for treatment-naïve HIV

31 Aug 2022 by

Dual therapy with the fixed-dose combination of darunavir/ritonavir plus lamivudine effectively controlled HIV as the same combination with tenofovir in treatment-naïve patients with HIV, according to the phase IV ANDES trial presented at AIDS 2022.